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ABSTRACT 
OPTIMIZATION OF MELANOMA SKIN CANCER PROBE 
Sarah Elizabeth Lee Ballard M.S. 
Western Carolina University (April 2019) 
Director: Dr. Brian Dinkelmeyer   
The aim of our proposed research is to develop clinical tools for detecting cancer 
cells and to further expand methods for the early detection of cancer. The focus of this 
research is to optimize the synthesis of a probe for detecting melanocyte stimulating 
hormone(MSH) G-proteins that are present in melanocyte cancer cells. An europium 
complex was chosen since it is an excellent luminescent tag with a narrow emission 
band and has a long luminescent lifetime. MSH-4 peptide was selected as the analyte 
since it binds specifically with MSH G proteins in melanoma cells. The melanocyte 
stimulating hormone (MSH-4) and its analogs were synthesized via a solid phase 
peptide synthesis method using F-moc protocol. The lanthanide tag was synthesized by 
chelating 5-amine-1,10- phenanthroline to Eu(TTA)3(H2O) complex. A tetraethylene 
linker was successfully synthesized and attached to the phenanthroline ligand. This was 
done by oxidizing the monobenzyl tetraethylene glycol to a carboxylic acid and adding it 
to the 5-amino-1,10-phenathroline amine using a standard peptide coupling procedure. 
The linker synthesis was found to be reproducible. The chelation of the ligand to the 
europium TTA complex was also completed. All compounds synthesized were 
characterized using the following instrumentation: GC-MS, UV-Vis, HPLC, FT-IR, NMR 
and fluorescence spectroscopy.
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CHAPTER ONE: INTRODUCTION 
The US Cancer Statistics Working Group states that, in 2014, 76,665 people were 
diagnosed with melanoma and of those who were diagnosed, 9,324 people died from 
melanoma.1 Melanoma skin cancer is caused by the skin’s or eye’s over exposure to 
UV light which damages the DNA in the cell.2 When melanocytes in the body become 
cancerous the usual result is a “mole or lesion”-like tumor on the surface which can 
spread out all over the body and lead to cancers forming elsewhere.2 During the early 
stages of melanoma, the growth stays within 1mm in thickness and has not reached the 
blood vessels and can be removed fairly easily with a simple surgical procedure.2 
Studying melanocytes and their channeling pathways could lead to early detection of 
and fewer deaths from melanoma in the future. 
Bioconjugation is a set of techniques which allows for site specific creation of a 
covalent bond between a biomolecule and a chemical that has the desired properties.3 
This hybrid having properties of both components can serve as a more useful tool for 
site specific conjugation.3 This bioconjugation method for this project combines a 
melanocyte stimulating hormone (MSH) with a luminescent label that is separated by a 
polyethylene glycol linker. MSH (melanocyte stimulating hormone) corresponds to the 
melanocytes in the body which is part of the family of G-protein coupled receptors.4 
MSH has the potential to be a diagnostic tool for melanoma because it has been used in 
conjugation with cytotoxin and cytotoxic T-cells for killing melanoma cells by recognizing 
their MSH receptors.4 G-protein coupling receptors or GPCR’s are present in cells 
throughout most of the organs in the body.5 This receptor is a globular polypeptide 
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embedded in a cell’s surface which binds to a signaling molecule, causing a 
conformational change and activating a G-Protein on the interior of the cell acting like a 
switch, turning off or on through signal-receptor interactions on the cell’s surface as 
seen in Figure 1.5  
 
 
 
The MSH- peptide was made using Solid phase peptide synthesis. Solid phase 
peptide synthesis is a method of synthesizing peptides on a solid support or resin by a 
C-terminus. The peptide is the built backwards from C-terminus to N-terminus which is 
opposite of how are bodies make peptides.6 The amino acids(AA) are added on 
individually by first removing the protecting group on the current AA on the resin, a 
washing step to remove any soluble by-products, then coupling a protected AA, and 
followed by another wash step.6 These steps are repeated until the desired amount of 
peptide chain length has been reached. The peptide remains attached to the resin 
Figure 1: A G-Protein Coupled Receptor activating a cell’s signaling pathway through 
the presence of an agonist (signaling molecule).5 
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throughout the wash steps.6 The peptide will then be removed with a final cleaving step 
which will be strong enough to separate the peptide from the solid support. 6All of the 
reactions mentioned take place inside of a microwave that aids in speeding up the 
reaction.6  
Lanthanides can be used for biological imaging due to their long lifetime and 
narrow emission bands.7 Lanthanides exhibit these properties due to the shielding of 
the 4f orbitals by the filled 5s and 5p sub-shells.7 This makes excitation of f-orbital 
electrons difficult and prevents an emissive state and makes f to f* transitions forbidden. 
Due to this low likelihood of electric dipole f-f* transition, direct excitation of the 
europium(III) ion is difficult, an organic chromophore ligand is used as an antenna to 
transfer energy directly to a europium(III) complex as represented in Figure 2 and 
Figure 3.7    
 
Figure 2: Jablonski diagram showing the transfer of energy from the ligand to the 
europium ion and to the ground state via luminescence.7 
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Figure 3: Illustration of the antenna effect where energy is absorbed by the organic 
chelate and transferred to europium metal. 
 
Linkers are needed to separate the bioactive site from the luminescent tag. 
Tetra-ethylene glycol is commercially available and is commonly used in PEGylation 
synthesis, this will be used in the synthesis of this probe. Polyethylene glycol is a 
nontoxic and non-immunogenetic polymer that is used strategically to overcome 
disadvantages associated with some biopharmaceuticals.8 Some of these 
disadvantages include conformation, electrostatic binding, and hydrophobicity.8 Using 
PEGylation can improve pharmacokinetic behavior of drugs by changing the physical 
and chemical properties of the biomedical molecules.8 By changing the way the cell 
interprets the molecule the cell will not begin to break down the bioconjugate and the 
bioactive portion of the molecule can function without being hindered sterically by the 
luminescent label.8 The linker for this bioconjugate will be made with a benzyl protected 
polyethylene glycol (PEG) linkers through a modification of biological molecules by 
covalent bonding called PEGylation.8   
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The current probes used by dermatologist has short life only fluorescing for a 
short period of time. By having a longer life time and increasing the visibility of the 
probe, as compared to dyes that are currently being used today, this probe could aid in 
the further studies of melanoma skin cancer and could be used in the identification and 
removal of affected melanocytes. The goal of my part of the project is to optimize the 
synthesis of the linker system of the melanoma skin cancer probe in order to further 
separate the peptide and the tag. Without proper separation of the two active sites of 
this probe the two ends could hinder their effectiveness due to steric hinderance. 
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CHAPTER TWO: PROJECT DESIGN 
The aim of our proposed research is to develop clinical tools for detecting and studying 
G-proteins in cancer cells and to further expand methods for the early detection of 
cancer. The essential feature of our design is attaching an easily detectable fluorescent 
probe molecule to a peptide substrate which specifically binds to melanocytes. A 
successful design must meet two criteria; First, the fluorescent probe must be easily 
detectable over the background fluorescence of biological samples. Second, the 
florescent probe must be attached to the substrate peptide such that it does not 
interfere with its normal binding to the G-protein binding site. This configuration is only 
possible if the label and peptide are separated by the linker enough to prevent steric 
interference. Our proposed structure is shown in Figure 4. 
 
Figure 4: Generalized structure of the proposed probe. 
 
 
The synthetic strategy that was settled upon involved first synthesizing the 
ethylene glycol linker-phenanthroline unit.  This would then be attached to the MSH-4 
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peptide using solid-phase peptide techniques (Scheme 1).  The europium TTA complex 
phenanthroline will be formed last after the MSH4-linker-ligand compound is cleaved 
from the resin. 
 
Scheme 1: Synthesis of MSH-4 (1) and attachment of the linker and ligand (2). 
 
 
The proposed synthesis of the linker-phenanthroline unit is shown in Scheme 2.   
The plan entails synthesizing mono-benzyl protected tetra-ethylene glycol (2) which can 
be oxidized to a carboxylic acid (3) or tosylated to form compound 4.  The carboxylic 
acid terminated 3 is then coupled to the 5-amine-1,10-phenanthroline ligand.  The 
length of the ethylene glycol unit can be progressively made longer by first removing the 
benzyl group followed by reaction with the tosylated compound 4.  Repetition of these 
steps will result in phenanthroline ligands with longer and longer ethylene glycol tails.  
Finally, the PEGylated phenanthroline ligands can be oxidized to create a carboxylic 
acid that can be coupled to the MSH-4 peptide on the solid support.    
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The first part of the probe synthesis, involves the synthesis of 5-amino-1,10-
phenanthroline(5) ligand which will be used as to create the antenna effect will be made 
from commercially available 1,10-phanathroline. The linker system will be attached to 
this ligand in order to separate the two active ends of the probe. The linker system will 
be synthesized from benzyl protected tetra-ethylene glycol which has either been 
tosylated or oxidized to a carboxylic acid. The carboxylic acid linker can be attached to 
the 5-amine-1,10-phenanthroline and sequentially lengthened by deprotecting followed 
by reaction with the tosylated linker (Scheme 2).  
 
 
Scheme 2: Proposed synthesis of ethylene glycol linker-phenanthroline probe. 
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The synthesis of the monobenzyl tetraethylene glycol (2) and tosylated glycol 
monobenzyl (4) compounds will be performed on a large scale to produce large 
quantities since these compounds will be used multiple times during the chain 
lengthening phase of the synthetic strategy.  The 5-amine-1,10-phenanthroline (5), 
synthesized previously, will then be added to the 1-Phenyl-2,5,8,11-tetraoxatridecan-13-
oic acid (3).  The benzyl protecting group is removed and more of the linkers can be 
added on sequentially. 
The MSH-4 peptide is made using solid phase peptide synthesis with a standard 
F-moc deprotection protocol on a solid support. This involves the deprotection of an F-
moc-protected N-terminus and its subsequent coupling which is all done in a microwave 
synthesizer. The coupling is confirmed via Kaiser test and the process is repeated to 
yield highly pure peptides. The beta varieties of the MSH-4 has an additional Proline-
Glycine on the end to provide more distance between the binding site and the 
luminescent tag. These peptides will be characterized using HPLC and LCMS.  
After the synthesis of the MSH-4 peptide, the benzyl protected end of the linker 
attached to the ligand is deprotected and converted to a carboxylic acid.  This is then 
coupled to the peptide which is on solid support. The ligand-peptide complex is then 
cleaved from solid support. After cleavage the Europium TTA (7) complex is added to 
the ligand completing the probe as shown in Scheme 2. The probe will be complete 
when the luminescent label is added as shown in Scheme 2. 
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CHAPTER THREE: EXPERIMENTAL 
3.1 General information  
Unless otherwise stated, all solvents and other reagents are commercially available and 
were used without further purification. All reagents were weighed and handled in air at 
room temperature. All thin-layer chromatography (TLC) was done with Sorbtech silica 
gel plated w/UV254. Silica used for all column chromatography was Silicycle R030B 40-
63µm. The NMR used is a JEOL 300MHz Eclipse. Chemical shifts(δ) are quoted in 
ppm. Multiplicity is reported with the following abbreviations: s= singlet, d = doublet, t = 
triplet, q = quartet, dt = doublet of triplets, td = triplet of doublets, tt = triplet of triplets.  
The GC-MS used was an Agilent 7890A paired with a 5975C mass spectrometer 
capable of both electron ionization (EI). The IR used was a Perkin Elmer SpectrumONE 
FTIR with diamond ATR. The UV-Vis used was an Agilent Cary 5000 UV-VIS-NIR 
system. The Fluorometer used was a Perkin Elmer LS-55 spectrometer. 
3.2 Synthesis and characterization of monobenzyl tetraethylene glycol (2)9  
This synthesis was modified from the synthesis found in the Niederer, K. et. al. paper.9 
Tetra-ethylene glycol (60.0 mL, 60.54g, 0.312mol, 3.95eqv.) was added to 165 mL of 
aqueous NaOH solution (50% m/m) and was stirred at room temperature for 20 min. 
9The solution formed a gel that was difficult to stir.9  Benzyl bromide (10.8mL, 15.552g, 
0.091mol, 1.0 eqv.) was then added to the mixture solution. 9The mixture was refluxed 
and stirred for 24 h and then cooled to room temperature.9 The mixture was separated 
retaining the dark top layer.9 The top layer was diluted with water (50 mL) and its pH 
adjusted to 4 with 2M HCl.9 The acidified reaction mixture was extracted three times 
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with 50 ml diethyl ether. 9 The combined ether layers were washed with brine and dried 
over MgSO4.9  The solvent was removed by rotary evaporation providing 17.5457g of 
crude reaction mixture containing the mono and dibenzyl derivatives.  The residue was 
purified by dry column chromatography eluting with 1:1 ethyl acetate/n-hexane while 
gradually increasing the proportion of ethyl acetate (Rf =0.5 ) to afford 6.6576g (6.1mL, 
74%) of the desired product as a light yellow oil.  H1 NMR (300MHz, CDCl3, TMS) 
:3.66(m,16H), 4.56(s, 2H), 7.33ppm(d,5H).   13C NMR (300MHZ,CDCl3): 61.72, 69.39, 
70.31, 70.58, 70.60, 72.90, 73.23, 127.59, 127.76, 128.34, 138.16ppm.  IR(ATR): 
3443.48, 2866.56, 1719.23, 1453.94, 1350.19, 1093.77, 939.42, 885.20, 738.56, 698.33 
cm-1.  MS(ESI)10.479 minutes: 281.1 m/z, 207.0, 135.0, 117.0, 91.1, 58.1, 32.0. The 
structure is shown in Figure 5. 
OH
O
O
O
O
 
Figure 5: Structure of Monobenzyl tetraethylene glycol (2). 
 
3.3 Synthesis and characterization of tosylated tetraethylene glycol monobenzyl 
(4)10 
This synthesis was modified from the synthesis found in the Yoshimoto, M. et. al. 
paper.10 In a dry round bottom flask, mono-benzyl tetra-ethylene glycol (0.519g, 
0.00175mol, 1eqv.)  and tosylchloride (0.8150g, 0.00427mol, 4eqv.)  was dissolved in 
dry methylene chloride(28.5mL) and KOH (0.2407g, 0.00439mol, 2.5eqv.) was added.10 
This mixture was then cooled to -10C with an ice/salt bath and slowly over 5 minutes. 
The mixture was allowed to stir and reach room temperature overnight becoming less 
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translucent as the reaction progressed.10 Then a saturated aqueous ammonium chloride 
solution was added followed by extraction with methylene chloride.10 The organic layers 
were then washed with saturate ammonium chloride and sodium bicarbonate and then 
with ammonium chloride again. The mixture was then dried with brine and magnesium 
sulfate. The solvent was removed by rotary evaporation to produce clear almost 
colorless oil. Flash column chromatography was performed using 1:1 hexanes to ethyl 
acetate.(100:0 v/v, Rf = 0.25). the yield was 0.586g (39% yield). H1NMR (300MHz, 
CDCl3, TMS): 2.43(s,3H), 3.67(m,14H), 4.12(t,3H), 4.56(s,2H), 7.34(m,5H), 7.82(d,2H).  
13C NMR (300 MHZ, CDCl3): 68.75, 69.33, 69.49, 70.69, 73.32, 127.15, 127.85, 128.07, 
128.45, 129.90, 130.32, 133.07, 138.29  ppm. IR (ATR): 2869.95, 1701.06 , 1597.17, 
1495.81, 1453.59, 1292.67, 1354.45, 1249.67, 1189.15, 1017.66 , 915.86, 814.22, 
774.13, 747.79 , 699.05, 662.55, 654.93,571.16, 528.59 cm-1. MS(EIS): 355.0 m/z, 
327.1, 281.1, 243.1, 199.0, 155.0,119.0, 91.0, 45.0. The structure is shown in Figure 6. 
S
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O
O
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O
 
Figure 6: Structure of Tosylated Tetraethylene glycol monobenzyl (4). 
 
3.4 Synthesis and characterization of 5-amino-1,10-phenathroline(5)11  
This synthesis was modified from the synthesis found in the Binnemans, K. et. al. 
paper.11 5-nitro-1,10-phenanthroline (2.0196g, 8.975mmol, 1.0 eqv.) was added to a 
250 round bottom flask and dissolved in ethanol(90.2mL) and sonicated for 1 hour at 
room temperature.11 After dissolution the solvent was purged with argon and a 10% 
13 
 
Pd/C catalyst (0.09g) was added along with a stir bar.11 The reaction was capped with a 
septum and purged with argon, hydrazine monohydrate (7.6mL, 0.1569mol, 17.5 eqv.) 
was added in slowly.11 The reaction was heated to 65C and stirred over-night. After 
reaction was complete the catalyst was removed via vacuum filtration. After filtration the 
solution was dissolved in chloroform and washed thrice with water to remove the excess 
hydrazine monohydrate.11 The organic layer was then placed under reduced pressure 
and the product was a yellow/green color 0.8121g(53.6% yield).  H1 NMR (300MHz, 
CDCl3, TMS): 1.237ppm (m,1 H)1.689ppm (s, 5H) 4.903ppm(s,4H), 6.941ppm (s,1H), 
7.500ppm (m,1H), 7.652 (m,1H), 7.962 (m, 1H), 8.263 (m,1H), 8.936(m,1H), 9.194 
(m,1H). 13C NMR (300MHZ,CDCl3): 106.59, 126.64, 126.89, 135.39, 135.65, 137.54, 
137.54, 137.54, 145.30, 147.51, 149.63, 150.98, 154.16, 177.74 ppm.  IR(ATR):3335.53 
cm-1, 2866.56 cm-1, 1722.49 , 1633.90, 1611.04, 1488.83 , 1406.97, 1270.98, 1133.96 , 
802.28, 736.85, 707.52 , 531.87 cm-1. The structure is shown in Figure 7. 
N
N
NH2
 
Figure 7: Structure of 1,10-phenathroline-5-amine (5). 
 
3.5.a Synthesis and characterization of 1-Phenyl-2,5,8,11-tetraoxatridecan-13-oic 
acid (3)12 
This synthesis was modified from the synthesis found in the Kichler, A et. al. paper.12 
Monobenzyl tetraethylene glycol (2.0151g, 0.00696mol,)was dissolved in acetone (92 
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mL) in a 250mL round bottom flask. Jones reagent (4.0 ml), consisting of 25g CrO3  in 
25mL of concentrated H2SO4 and 75mL H2O was added to the round bottom slowly over 
20min with stirring.12 The mixture was stirred at ambient temperature for 1 hour. To this 
mixture was then added 3mL of 2-propanol and allowed to stir or twenty minutes.12 
Water (61.2 mL)was then added and the mixture vacuum filtered to remove excess 
chromium oxide.12 The acetone was removed by rotary evaporation. An extraction was 
preformed using dichloromethane(DCM) in 20 mL increments totaling up to 12 times.12 
The organic layers were then dried with magnesium sulfate and the DCM was removed 
under vacuum pressure. The resulting oil was then placed under vacuum  to remove 
solvent and the oil was placed in the freezer. Yield was 2.176g (38%). 
3.5.b Purification of 1-Phenyl-2,5,8,11-tetraoxatridecan-13-oic acid (3) via ion 
exchange chromatography.13  
This purification step was done via ion exchange resin modified from the procedure 
developed by Bookser, B. C. et. al.13  The ion exchange resin used to purify was 
Dowex1X2-400(5.053g), which was swelled in methanol(25mL) overnight then drained 
off the methanol.13 Then some of the carboxylic acid(1.0076g,0.0034mol,1eqv.) and 
DIEA(0.8799g,0.068mol, 2eqv.) were mixed with 25ml of methanol and then added to 
the resin.13 This mixture was allowed to sit for 1 hour.13 Then the resin was washed with 
methanol and the wash was collected.13 To the resin was added a solution of 95:5 
Methanol: TFA (100mL) and allowed to sit for 30 minutes then the solvent was collected 
and the resin was washed with more of the 95:5 Methanol: TFA(100mL) this was 
collected and the solvent was removed via vacuum.13 The light yellow oil was collected 
and determined to be two separate carboxylic acids according to the GC-MS. H1 
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NMR(300MHz,CDCl3,TMS): 3.62-3.74 (m,13H), 4.13-4.15 (d,2H), 4.58(s, 2H), 7.25-
7.33(m,5H).  13C NMR (300MHZ,CDCl3): 0.073, 51.883, 68.710, 69.482, 70.726, 
71.395, 73.331, 74.202, 127.853, 138.291, 171.015ppm.  IR(ATR):3348.08 cm-1, 
2875.57, 1734.82 , 1453.91, 1351,19, 1218.46, 1086.34, 1017.67, 943.83, 848.11, 
740.84, 699.05 cm-1.  MS(ESI) 9.785 minutes : 268.1 m/z, 209.2, 191.0, 162.1, 135.1, 
116.1, 91.1, 59.1, 39.1.  MS(ESI) 10.864 minutes: 340.9 m/z, 312.2, 269.1, 237.3, 
206.1, 179.1, 148.1, 117.1, 91.1, 59.1, 31.1. The structure is shown in Figure 8. 
 
Figure 8: Structure of 1-Phenyl-2,5,8,11-tetraoxatridecan-13-oic acid (3). 
 
3.6.a Synthesis and characterization of N-(5-phenanthryl)-12-benzyl-3,6,9,12-
tetraoxa dodecamide (Phen-4EG-BZ) (6)14  
This synthesis was modified from the synthesis found in the Elmes, R. B. P. et. al. 
paper.14 To a 250mL round bottom flask was added 5-amine phenanthroline(0.5056g, 
2.59mol, 1eqv.) dissolved in 100mL of DCM and cooled to 0C via ice bath.14 The 1-
Phenyl-2,5,8,11-tetraoxatridecan-13-oic acid (0.653g, 2.19mmol, 1eqv.) was added to the 
flask.14 DMAP(0.31g, 2.537mmol) and EDCI(1.23g, 7.91mmol) are added and the flask and the 
mixture is allowed to stir at 0C for an hour and allowed to reach room temperature over-
night.14 The solvent was removed from the mixture and then water(50mL) was added to 
the reaction.14 The water mixture was then extracted with DCM. The organic layers 
were collected and the solvent was removed from the product to afford a brownish- 
O
O
O
OOH
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green solid(0.4073g).14 This solid was then dissolved in DCM and then ran through a 
silica plug using 1:25 methanol to chloroform as a eluent to remove unreacted 5-amine 
phenanthroline.14 The sample was then dissolved in methanol (25mL) and purified via 
ion exchange resin.13 
3.6.b Purification of N-(5-phenanthryl)-12-benzyl-3,6,9,12-tetraoxa dodecamide 
(Phen-4EG-BZ) (6)13 
This purification step was modified from the Bookser, B. C. et. al.13 The ion exchange 
resin used to purify was Dowex1X2-400(5.278g), which was swelled in methanol(25mL) 
overnight then drained off the methanol.13 Then the dissolved solid was added to the 
resin.13 This mixture was allowed to sit for 1 hour. Then the resin was washed with 
methanol and the wash was collected.13 To the resin was added a solution of 95:5 
methanol: TFA (100mL) and allowed to sit for 30 minutes then the solvent was collected 
and the resin was washed with more of the 95:5 methanol: TFA (100mL)this was 
collected and the solvent was removed via vacuum.13 The first wash of methanol was 
collected and the solvent was removed under vacuum yielding a dark orange 
solid(0.476g, %). The methanol: THF wash was found to contain unreacted carbocyclic 
acid. DIEA was found to still be in the final product.  H1 NMR(300MHz,DMSO D-
6,TMS):1.24-1.29 (m,1H),3.51-3.62(m,15H), 4.12(s, 2H), 4.47(s, 2H), 6.91(s, 1H), 7.26-
7.34(m, 5H), 7.61-7.65(m,1H), 7.80-7.84(m, 1H), 8.22-8.25(m,1H), 8.69-8.71(m,1H), 
8.76-8.79(m,1H), 9.09-9.10(m,1H).   IR(ATR): 3416.51 cm-1, 3322.44, 3208.13, 
2863.63, 2083.69, 1754.28, 1635.6, 1610.32, 1592.67, 1552.67, 1543.56, 1504.88, 
1489.03 , 1455.50, 1428.02, 1406.73, 1302.57, 1271.70 , 1254.34 , 1215.84, 1107.28, 
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1032.94, 885.85, 841.79, 825.85, 812.54, 792.22, 738.51, 707.05, 650.88, 620.62 cm-1. 
The structure is shown in Figure 9 
 
Figure 9: Structure of Phen-4EG-BZ (6). 
 
3.7 Synthesis and characterization of monotetrahydropyran-protected 
tetraethylene glycol (THP-4EG)15 (7) 
This synthesis was modified from the synthesis found in the paper by Loiseau, F. 
A. et. al.15 To a 1000mL flask was added Tetraethylene glycol (100mL, 0.579mol, 
4.9eqv.) and (0.0360g,0.209mmol,1.8eqv.)p-toluene sulfonic acid.15 This was dissolved 
in dichloromethane (300mL) and allowed to stir at room temperature.15 To this mixture 
was added dropwise 3,4 dihydro-2,4-pyran 99% (9.9657g, 0.1185mol, 1eqv.).15 This 
mixture was allowed to react over-night while stirring.15 Half of the solvent was removed 
via rotary evaporation.15 Water(300mL) was then used to wash the mixture, the organic 
layer was collected then washed with a brine mixture (100mL) six times.15 The organic 
layer was then dried using sodium sulfate.15 The remaining solvent was removed from 
the organic layer resulting in a clear oil (12.8846g). The oil was then proven to be a 8 to 
1 ratio of mono substituted to di substituted linker via GC-MS.  H1NMR (300MHz, 
CDCl3, TMS): 1.50-1.60(m,6H), 2.76-2.78(m,1H), 3.50-3.70(m,15H), 3.85-3.87(m, 2H), 
4.61-4.63(m,1H).  C13 NMR (300MHZ,CDCl3):19.39, 25.36, 30.46, 62.69, 70.30, 70.49, 
N
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70.53, 70.56, 70.59, 72.50, 98.88ppm. IR(ATR): 3450.21 cm-1, 2939.24, 2868.64, 
1454.79,1349.99, 1284.86,1258.79,1201.55,1184.01 ,1120.70 , 986.70 , 929.61, 871.68 
, 813.71, 792.27 cm-1.  MS(ESI)13.141 minutes: 195.0 m/z, 165.0, 150.9, 133.0, 119.0, 
101.0, 85.0, 72.0, 58.1, 45.0, 32.0.  MS(ESI)16.019 minutes: 280.8 m/z, 259.0, 206.9, 
188.8, 164.9, 133.0, 114.9, 85.0, 55.0, 32.0. The structure is shown in Figure 10. 
 
Figure 10: Structure of Monotetrahydropyran-protected tetraethylene glycol (THP-4EG). 
 
3.8 Europium(III)(TTA)3 (H2O)2(8)16  
This synthesis was modified from the synthesis found in the Leonard, J. P. et. al. 
paper.16  2-Thenoyltrifluoroacetone (0.67 g; 3 mmol, 3eqv.) was dissolved in 1M NaOH 
(3 mL) and water (20mL).16 A solution of EuCl3• 6H2O (0.37 g; 1 mmol,1eqv.) in 10 mL 
of water was made.16 The two solutions were stirred separately until completely clear 
the TTA solution was added dropwise to the europium solution.16 A precipitant formed 
and was removed via vacuum filtration and washed with water (200 mL). the precipitant 
was then washed with diethyl ether to dry the solid. Yield was  0.689g (81% yield) of 
solid europium(III)(TTA)H2O.  IR(ATR): 3356.28 cm-1,1600.19, 1580.90, 1538,1509, 
1459, 1406.84, 1356.77, 1285.55,1247.95, 1230.82, 1131.99, 1080.82, 1051.10, 
1037.14, 929.00, 850.11, 786.77, 751.11, 734.02 , 711.07, 698.81, 680.58 , 604.08. 
UV/Vis λmax: 343 nm. Fluoresce λmax: 615.5 nm. The structure is shown in Figure 11. 
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Figure 11:Structure of Europium(III)(TTA)3 (H2O)2 Complex. 
 
3.9 Europium(TTA) 5-amine phenanthroline(9)11  
This synthesis was modified from the synthesis found in the Binnemans K, et. al. 
paper.11 To a 100ml Round bottom flask was added Europium(TTA)3 H2O (0.1090g, 
0.1303mmol, 1eqv.) and dissolved in DCM (30mL).11 In a separate flask 5-amine 
phenanthroline(0.0236g, 0.1303mmol, 1eqv.) was dissolved in DCM(30mL).11 The 5-
amine phenanthroline mixture was added to the europium TTA mixture and stirred at 
60C for 30 minutes.11 After heating, the mixture was allowed to stir overnight.11 The 
mixture was placed in a scintillation vile and the solvent was allowed to evaporate out 
leaving a very small amount of solvent that will be removed via vacuum filtration.11 The 
crystal yield was 0.0365g (30% yield).  IR (ATR):1598.14 cm-1, 1588.94, 1505.95, 
1450.58, 1412.26, 1355.88, 1305.95,1248.92, 1231.71, 1192.50, 1132.55, 1062.85, 
933.34, 859.32, 787.07, 734.93, 714.76, 683.05, 640.85. UV/Vis λmax: 340 nm. 
Fluorescence λmax: 615 nm. The structure is shown in Figure 12. 
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Figure 12: Structure of Europium(TTA) 5-amine phenanthroline Complex. 
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CHAPTER FOUR: RESULTS AND DISCUSSION  
4.1 Statement of previous plans and redirection 
The project is not complete but significant progress has been made. Linker synthesis 
has been optimized. The coupling of the linker to the ligand has been achieved. The 
synthesis of the europium TTA water was achieved. The chelating of 8 to the ligand (5) 
has been achieved.  Our initial synthetic strategy has changed due to time constraints 
and technical difficulties. Originally, ethylene glycol linkers of varying length were to be 
synthesized by systematically combining monobenzyl mono-tosylated tetraethylene 
glycol (4) with THP protected tetra ethylene glycol (7). This would produce a longer 
ethylene chain with different protecting groups at each end.  Selective removal of the 
THP protecting group followed by addition of 4 would lengthen the chain by four 
ethylene glycol units.  Repeating the process would lengthen the chain further as seen 
in Figure 13.    
 
 
Figure 13: Initial Synthetic Strategy. 
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The Benzyl/THP protected chains would be deprotect and tosylate followed by 
attachment to 5-aminophenathroline by an SN2 reaction (Fig.14). This synthetic plan 
ultimately failed and required us to reevaluate the strategy. The amine group on the 5-
amine 1,10-phenathroline was found to be a poor nucleophile because of the nitrogen 
lone pair electrons are stabilized by resonance to an electron withdrawing aromatic ring.  
Additionally, the reaction was moisture sensitive and drying reactants and reagents was 
problematic.  Both the ethylene glycol compounds and the 5-aminophenathroline 5 were 
extremely hygroscopic.  
 
 
Figure 14: Unsuccessful coupling attempt of tosylated monobenzyl tetraethylene glycol 
to 5-amine 1,10-phenathroline. 
 
The original reaction was preformed using toluene as a solvent with triethylamine 
to deprotonate the amine group, this was found to be unsuccessful. Great care was 
taken to dry all of the solvents and reagents used. Solvent stills were used to dry both 
the toluene and triethylamine. The 5-aminophenathroline was dried by removing water 
as an azeotrope from toluene. Despite these careful precautions the reaction was still 
unsuccessful. Other literature procedures with different solvents and bases were then 
tried.  The toluene/triethylamine was replaced with dry THF/ K2CO3 which this was also 
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unsuccessful. The reaction was attempted with microwave heating which was also 
unsuccessful.  After multiple attempts and months of research the synthetic plan was 
shortened and changed.   
The new synthetic plan relied on oxidizing the monobenzyl tetraethylene glycol to 
a carboxylic acid.  This would then be added to the 5-amine1,10-phenanthroline(5) 
using techniques generally used in peptide synthesis (Figure 15). This was determined 
to be plausible and the synthesis was carried out using DMAP and EDIC to couple the 
carboxylic acid(3) to the amine group(5), this was successful. The plan for addition of 
the linkages will now be to add the tosylated monobenzyl tetraethylene glycol(4) on to 
the coupled reaction(6) after removal of the benzyl group. The following sections detail 
the progress made in synthesizing the phenanthroline linker system.     
 
 
 
Figure 15: New coupling synthesis. 
     
4.2 Synthesis and characterization monobenzyl tetraethylene glycol (2)9 
This synthesis was modified from the synthesis found in the Niederer, K. et. al. paper.9 
Tetra-ethylene glycol was added to aqueous NaOH solution and was stirred at room 
temperature for 20 min this mixture was very thick and was a yellowish color. After 
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adding the benzyl bromide the solution formed an orange top layer with a cream colored 
liquid at the bottom. After refluxing for 24 h and then cooled to room temperature the top 
layer as now thick and burgundy, while the bottom layer was still a cream color. The 
mixture was separated retaining the dark top layer.  The top layer was diluted with water 
and acidified dark solids were observed. The acidified reaction mixture was extracted 
three times with diethyl ether and the clear combined ether layers were washed with 
brine and dried over MgSO4.  The solvent was removed yielding a dark transparent 
orange oil containing a mixture of mono and dibenzyl derivatives. The residue was 
purified by dry column chromatography yielding a light yellow oil.  
The H1 NMR spectrum confirmed that the reaction was a success.   The singlet 
at 4.56ppm corresponds to the CH2 benzyl hydrogens. The multiplet at 7.33ppm 
corresponds to the five hydrogens of the benzyl group. The 13C NMR showed the 11 
expected carbon peaks. GC-MS was used to determine purity and the presence of 
functional groups.  A molecular ion peak could not be found because ethylene glycol 
chains fragment easily in ESI MS.  The mass spectra of that peak indicated presence of 
the benzyl group giving a large peak at 91.1m/z. The product was analyzed via IR and 
confirms the presence of the benzyl group at approximately 3100 cm-1 (aromatic peak). 
The tetraethylene glycol at 1350.19 cm-1 (C-O stretch) and a strong 1093.77 cm-1 (C-O 
stretch). Also the primary alcohol at 3443.48cm-1 (OH stretch). (H1 NMR , C13 NMR, IR, 
and GC-MS spectra found in supplemental material section.)   
4.3 Synthesis and characterization of tosylated tetraethylene glycol monobenzyl 
(4)10 
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This synthesis was modified from the synthesis found in the Yoshimoto, M. et. al. 
paper.10  Benzylbromide was allowed to react with an excess of tetrethyleneglycol and 
excess of concentrated sodium hydroxide.10 Excess tetrethylene glycol was removed by 
extyraction yielding a mixture of mono- and di-protected product. Column 
chromatography was used to isolate the monobenzyl tetraethylene glycol.10 The product 
was identified using H1 NMR. The singlet at 2.43ppm corresponds to the methyl on the 
tosylate group. The multiplet at 3.67ppm corresponds to the methylenes on the 
tetraethylene glycol . The triplet at 4.12ppm corresponds to the terminal methylene 
adjacent to the tosyl group. The singlet at 4.56ppm is from the benzyl methylene group. 
The multiplet at 7.34ppm corresponds to the aromatic hydrogens of the benzyl 
protecting group. The doublets in the aromatic region correspond to the tosylate group 
hydrogens. The  C13 NMR showing 13 carbon peaks as expected. The IR spectrum 
confirms the presence of the tosyl group at 1354.45 cm-1 (S=O asymmetric stretch), and 
1017.66 cm-1 (S=O  symmetric stretch). The benzyl group at approximately 3100 cm-1 
(aromatic peak). The GC-MS of the purified product shows the presence of tosylate 
group because of the large peaks at 155m/z ( C6O2S) and  91m/z (C7H7). The benzyl 
group can also be confirmed due to the large size of the 91m/z peak. (H1 NMR , C13 
NMR, IR, and GC-MS spectra found in supplemental material section.)  
4.4 Synthesis and characterization 1,10-Phenathroline-5-amine (5)11 
This synthesis was modified from the synthesis found in the Binnemans, K. et. al. 
paper.17 5-nitro-1,10-phenanthroline was reduced to the amine with 10% Pd/C and 
hydrazine.17  After reaction, the catalyst was removed filtration and the filtrate washed 
with water to remove the excess hydrazine monohydrate.17 The mostly pure product 
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was recrystallized from absolute ethanol and cyclohexane.17 The H1 NMR of the product 
had the expected peaks. The singlet at 6.941 ppm corresponds to the amine group. The 
peaks at 7.652, 7.962, 8.263, 8.936, and 9.194 correspond to the aromatic hydrogens 
on the 1,10-phenathroline. The C13 NMR showed fourteen peaks in the aromatic region 
as expected. The IR spectrum had bands at 3335.53 and 3222.81 cm-1  indicating that 
an amine had formed (H-N-H asymmetric/symmetric).  The absence of N=O nitro 
stretch also confirms the formation of the amine. (H1 NMR , C13 NMR, IR, and GC-MS 
spectra found in supplemental material section).    
4.5 Synthesis and characterization of 1-phenyl-2,5,8,11-tetraoxatridecan-13-oic 
acid (3)12,13  
This synthesis was modified from the synthesis found in the Kichler, A et. al. paper. 
Monobenzyl tetraethylene glycol was oxidized to a carboxylic acid using Jones reagent.   
The reaction mixture turns orange when the jones reagent is added and then as the 
jones reagent oxidizes the mixture turns teal with dark teal solid.  The color change is a 
good indication that the chromium agent is being consumed and that the carboxylic acid 
is forming. The crude product was a clear oil that contained many side products. The 
acidic reaction conditions were harsh and resulted in cleavage of the ethylene glycol 
chain.  Some of these ethylene glycol fragments were further oxidized to mono and 
dicarboxylic acids. Most of these side products were successfully removed by sending 
the reaction mixture through a silica plug. Further purification by column 
chromatography was unsuccessful.    
Further purification required using an ion exchange resin. This purification step 
was modified from the Bookser, B. C. et. al. paper.13 Dowex 1x2 (Cl) ion exchange resin 
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was swelled overnight with methanol.13 The swelled resin was fluffy in texture and had a 
yellowish white appearance.13 The product mixture was combined with DIEA in 
methanol and added to the swelled ion exchange resin and allowed to sit for one hour.13 
The addition of DIEA is believed to improve the effectiveness of the ion exchange resin 
in adsorbing carboxylic acids.13 The resin was filtered and the filtrate analyzed to 
determine if the carboxylic acid (3) had been adsorbed. The carboxylic acid (3) was 
displaced from the resin by washing it with a CH3OHl/TFA solution.  After removal of the 
CH3OHl/TFA, the resulting oil was then characterized by GC/MS.  The oil consisted 
primarily of the desired product 3 with a small amount of impurity present.  The mass 
spectrum of the impurity was extremely similar to the product. Carboxylic acid (3) was 
used without further purification.   
The H1 NMR confirmed the identity of the product. The peak at 3.62-3.74 ppm 
(m,13H) correlates to the ethylene glycol CH2 units. Peak at 4.13-4.15 ppm (d, 2H) and 
4.58 ppm (s,2H) correlates to the methylenes adjacent to the carboxylic acid.   The IR 
spectrum confirmed the presence of a carboxylic acid.  The appearance acid of a peak 
at 170.9 ppm in the C13 NMR also indicated that a carboxylic had been made.  The MS 
data of the larger peak shows peaks indicating loss of a carboxylic acid at 59.1m/z 
(C2H3O2). The MS data also confirms the presence of a carboxylic acid and benzyl 
group with peaks at 59.1 m/z (CH2CO2H) and  91.1 m/z (C7H7). (H1 NMR , C13 NMR, 
IR, and GC-MS spectra found in supplemental material section.)      
4.6 Synthesis and characterization of N-(5-phenanthryl)-12-benzyl-3,6,9,12-
tetraoxa dodecamide (Phen-4EG-BZ) (6)13,14  
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This synthesis was modified from the synthesis found in the Elmes, R. B. P. et. al. 
paper.14 Standard peptide coupling procedures (EDCI/DMAP) were used to attach 1-
phenyl-2,5,8,11-tetraoxatridecan-13-oic acid (3) to 5-amino-1,10-phenathgroline (5) to 
afford a light orange solid. The sample did not move on silica gel TLC plates so column 
chromatography could not be used to purify.  Instead, ion exchange resin was used to 
remove any unreacted carboxylic acid (3).  The unreacted carboxylic acid (3) was 
recovered by rinsing the resin with 95:5 methanol: TFA.  The H1 NMR confirmed the 
presence of the desired product.  The multiplet at 3.51-3.62 ppm corresponds to the 
fifteen hydrogens on the tetraethylene glycol portion of the product. The singlet at 4.12 
ppm corresponds to the O=C-CH2-O hydrogens adjacent to the amide. The singlet at 
4.47 ppm corresponds to the benzyl methylene group. The singlet at 6.91ppm 
corresponds to the aromatic methine on C6 of the phenanthroline. The multiplet at 7.26-
7.34 ppm corresponds to the hydrogens on the lone benzyl group on the end of the 
linker. The peaks at 7.61-7.65 ppm, 7.80-7.84 ppm, 8.22-8.25 ppm, 8.69-8.71 ppm, 
8.76-8.79 ppm, 9.09-9.10 ppm all correspond to aromatic hydrogens attached to the 
phenanthroline portion of the ligand. The FTIR spectrum confirmed the formation of an 
amide bond with peaks at 3415.51 cm-1 (amide N-H stretch) and 1635.64 cm-1 (amide 
N-C=O stretch). The appearance of a strong peak at 1107.28 cm-1 (C-O) indicates the 
presence of the tetraethylene glycol ether. (H1 NMR , C13 NMR, IR, and GC-MS spectra 
found in supplemental material section.)    
4.7 Synthesis and characterization of monotetrahydropyran-protected 
tetraethylene glycol (THP-4EG) (7)15 
29 
 
This synthesis was modified from the synthesis found in the paper by Loiseau, F. A. et. 
al.15 Tetraethylene glycol was reacted with 3,4 dihydro-2,4-pyran using p-toluene 
sulfonic acid as a catalyst to produce a clear colorless oil.  The oil contained the mono 
and di-protected product in a 8:1 ratio. Further use of compound 7 was not considered 
unnecessary since the synthetic strategy had changed (Fig. 15-16).  (H1 NMR , C13 
NMR, IR, and GC-MS spectra found in supplemental material section).   
4.8 Synthesis and characterization of Europium(III)(TTA)3 (H2O)2 (8)16 
This synthesis was modified from the synthesis found in the Leonard, J. P.et. al. paper.  
2-Thenoyltrifluoroacetone (TTA) was dissolved in water and NaOH and an aqueous 
EuCl3 solution was added dropwise. The solution was filtered to produce a white solid 
that was fluoresced orange under UV light and had the desired luminescent properties. 
The complex had an excitation wavelength of 340 nm and emission wavelength of 
615.5 nm. The product was analyzed via IR and had peaks at 3356.28 cm-1 (O-H) 
indicating the presence of water in the complex. Peaks were also found in 1131.99 cm-1 
(C-F stretch) and indicating the presence of TTA. (IR, UV-VIS, and Florescence spectra 
found in supplemental material section.)   
4.9 Europium(TTA) 5-amine phenanthroline(9)11  
This synthesis was modified from the synthesis found in the Binnemans K, et. al. 
paper.17 Europium complex 8 was combined with 5-amine phenanthroline in CH2Cl2 and 
stirred at 60 C for 30 min and then at room temperature overnight.  Small crystals 
formed upon evaporation of the solvent.17 The 5-aminophenthroline-europium complex 
9 had a much more intense fluorescent band 615.5 nm then starting complex 8. This is 
expected since the phenanthroline ligand is supposed to act as an antennae for 
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absorbing light and transferring the energy to the europium. (IR, UV-VIS, and 
Florescence spectra found in supplemental material section.)   
4.10 Conclusion 
In this project, the linker synthesis was found to be reproducible and the purification of 
the products can now be assured upon the improvement of the purification methods. 
This will allow for the ease of synthesis of the probe. The coupling of the linker was 
found to be successful, the purification is not complete until further purification can be 
completed. The purification steps isolated the unreacted products, those of which can 
be reused. Europium label synthesis has been accomplished and can now be used for 
further analysis. All components of this project were made, purified, and analyzed to 
insure optimal usage for future assembly of the probe. The linker synthesis has now 
been optimized allowing for extension of the N-(5-phenanthryl)-12-benzyl-3,6,9,12-
tetraoxa dodecamide (6). 
4.11 Future Work 
Future members of this research group can now work on adding more linkers to the 
ligand after purification and begin attempting to attach the linker to the MSH-4 peptide. 
The europium complexes will be added to the ligand attached with the inker to the MSH-
4. After the successful synthesis of the probe cell testing can be done.  
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benzyl-tetraethylene glycol (2): 4-EG-Bz 
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benzyl-tetraethylene glycol (2): 4-EG-Bz 
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benzyl-tetraethylene glycol (2): 4-EG-Bz 
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tetrahydropyranyl tetraethylene glycol (7)    
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tetrahydropyranyl tetraethylene glycol (7)    
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tetrahydropyranyl tetraethylene glycol (7)    
 
 
 
Mono-tosyl-mono-benzyl tetraethylene glycol (4)   
 
Ts-4EG-Bz-3.jdx
9 8 7 6 5 4 3 2 1
Chemical Shif t (ppm)
0
0.0000001
0.0000002
0.0000003
0.0000004
0.0000005
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
3.0414.762.052.006.971.91
2
.4
3
3
.5
7
3
.6
3
3
.6
5
3
.6
5
3
.6
6
3
.6
8
4
.5
5
7
.2
5
7
.3
2
7
.3
4
7
.7
7
7
.8
0
O
O
O
OO
S
OO
CH3
O
O
O
OOH O
39 
 
Mono-tosyl-mono-benzyl tetraethylene glycol (4)   
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Mono-tosyl-mono-benzyl tetraethylene glycol (4)   
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Mono-tosyl-mono-benzyl tetraethyleneglycol (4) 
 
 
 
1-phenyl-2,5,8,11-tetraoxatridecane-13-oic acid (3)   
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1-phenyl-2,5,8,11-tetraoxatridecane-13-oic acid (3) 
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1-phenyl-2,5,8,11-tetraoxatridecane-13-oic acid (3)  
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1-phenyl-2,5,8,11-tetraoxatridecane-13-oic acid (3) 
 
 
 
1-phenyl-2,5,8,11-tetraoxatridecane-13-oic acid (3) 
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N-(5-phenanthryl)-12-benzyl-3,6,9,12-tetraoxa dodecamide (6): Phen-4EG-BZ  
 
 
 
 
  
coupled reaction DMSO yeah.jdx
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N-(5-phenanthryl)-12-benzyl-3,6,9,12-tetraoxa dodecamide (6): Phen-4EG-BZ  
 
 
N-(5-phenanthryl)-12-benzyl-3,6,9,12-tetraoxa dodecamide (6): Phen-4EG-BZ  
 
 
 
coupled reaction DMSO yeah.jdx
9.5 9.0 8.5 8.0 7.5 7.0
Chemical Shif t (ppm)
0
0.0000001
0.0000002
0.0000003
0.0000004
0.0000005
N
o
rm
a
liz
e
d
 I
n
te
n
s
it
y
1.025.001.061.031.021.021.061.05
6
.9
1
7
.2
6
7
.2
9
7
.3
2
7
.3
4
7
.6
1
7
.6
3
7
.6
4
7
.6
5
7
.8
0
7
.8
1
7
.8
3
7
.8
4
8
.2
2
8
.2
5
8
.6
9
8
.6
9
8
.7
0
8
.7
1
8
.7
6
8
.7
6
8
.7
9
8
.7
9
9
.0
9
9
.0
9
9
.1
0
9
.1
0
N
N
N
H
O
O
O
O
O
N
N
N
H
O
O
O
O
O
47 
 
N-(5-phenanthryl)-12-benzyl-3,6,9,12-tetraoxa dodecamide (6): Phen-4EG-BZ  
 
 
 
Eu(TTA)3 (H2O)2 (8) 
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Eu(TTA)3 (H2O)2 (8) 
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Eu(TTA)3 5-amino-1,10-phenathroline (9) 
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Eu(TTA)3 5-amino-1,10-phenathroline (9) 
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